Dissociating Memory Networks in Early Alzheimer’s Disease and Frontotemporal Lobar Degeneration - A Combined Study of Hypometabolism and Atrophy

Frisch, Stefan; Dukart, Juergen; Vogt, Barbara; Horstmann, Annette; Becker, Georg; Villringer, Arno; Barthel, Henryk; Sabri, Osama; Müller, Karsten; Schroeter, Matthias L.
February 2013
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
Academic Journal
Introduction: We aimed at dissociating the neural correlates of memory disorders in Alzheimer’s disease (AD) and frontotemporal lobar degeneration (FTLD). Methods: We included patients with AD (n = 19, 11 female, mean age 61 years) and FTLD (n = 11, 5 female, mean age 61 years) in early stages of their diseases. Memory performance was assessed by means of verbal and visual memory subtests from the Wechsler Memory Scale (WMS-R), including forgetting rates. Brain glucose utilization was measured by [18F]fluorodeoxyglucose positron emission tomography (FDG-PET) and brain atrophy by voxel-based morphometry (VBM) of T1-weighted magnetic resonance imaging (MRI) scans. Using a whole brain approach, correlations between test performance and imaging data were computed separately in each dementia group, including a group of control subjects (n = 13, 6 female, mean age 54 years) in both analyses. The three groups did not differ with respect to education and gender. Results: Patients in both dementia groups generally performed worse than controls, but AD and FTLD patients did not differ from each other in any of the test parameters. However, memory performance was associated with different brain regions in the patient groups, with respect to both hypometabolism and atrophy: Whereas in AD patients test performance was mainly correlated with changes in the parieto-mesial cortex, performance in FTLD patients was correlated with changes in frontal cortical as well as subcortical regions. There were practically no overlapping regions associated with memory disorders in AD and FTLD as revealed by a conjunction analysis. Conclusion: Memory test performance may not distinguish between both dementia syndromes. In clinical practice, this may lead to misdiagnosis of FTLD patients with poor memory performance. Nevertheless, memory problems are associated with almost completely different neural correlates in both dementia syndromes. Obviously, memory functions are carried out by distributed networks which break down in brain degeneration.


Related Articles

  • Primary progressive aphasia: a comparative study of progressive nonfluent aphasia and semantic dementia. George, Annamma; Mathuranath, P. S. // Neurology India;Jun2005, Vol. 53 Issue 2, p162 

    Primary progressive aphasia (PPA), a degenerative disorder, is often misdiagnosed as Alzheimer's disease. Its subtypes, semantic dementia (SD), and progressive nonfluent aphasia (PNFA), are often difficult to differentiate from each other. Our objective was to highlight the differences in the...

  • Patterns of semantic memory impairment in Mild Cognitive Impairment. Joubert, Sven; Felician, Olivier; Barbeau, Emmanuel J.; Didic, Mira; Poncet, Michel; Ceccaldi, Mathieu // Behavioural Neurology;2008, Vol. 19 Issue 1/2, p35 

    Although the semantic memory impairment has been largely documented in Alzheimer's disease, little is known about semantic memory in the preclinical phase of the disease (Mild Cognitive Impairment). The purpose of this study was to document the nature of semantic breakdown using a battery of...

  • Kognitionsbezogene Interventionen bei Alzheimer-Krankheit. V.C. Buschert; K. Bürger // Der Nervenarzt;Mar2009, Vol. 80 Issue 3, p273 

    Zusammenfassung  In Deutschland leiden derzeit über 1 Mio. Menschen an Alzheimer-Demenz (AD). Bis zum Jahr 2050 wird eine Verdoppelung der Zahl der Erkrankten erwartet. Die Wirksamkeit derzeit zugelassener, spezifischer Antidementiva zur symptomatischen Behandlung der AD ist nicht...

  • Clinical Profile of PiB-Positive Corticobasal Syndrome. Burrell, James R.; Hornberger, Michael; Villemagne, Victor L.; Rowe, Christopher C.; Hodges, John R. // PLoS ONE;Apr2013, Vol. 8 Issue 4, p1 

    Background: Corticobasal syndrome (CBS) is a multifaceted neurodegenerative disorder characterized by a combination of motor and cognitive deficits. Several different pathological entities, including Alzheimer’s pathology, have been described in association with CBS. The present study...

  • Modulation of Hsp90 function in neurodegenerative disorders: a molecular-targeted therapy against disease-causing protein. Waza, Masahiro; Adachi, Hiroaki; Katsuno, Masahisa; Minamiyama, Makoto; Tanaka, Fumiaki; Doyu, Manabu; Sobue, Gen // Journal of Molecular Medicine;Aug2006, Vol. 84 Issue 8, p635 

    Abnormal accumulation of disease-causing protein is a commonly observed characteristic in chronic neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease, and polyglutamine (polyQ) diseases. A therapeutic approach that could selectively eliminate would be a...

  • What's the best test for early detection of memory decline?  // Podiatry Review;Nov/Dec2013, Vol. 70 Issue 6, p14 

    The article discusses a study regarding Food for the Brain's online Cognitive Function Test (CFT), which found that it can provide accurate measurement that indicates risk of Alzheimer's Disease. It says that the advantage of the CFT is its being free and digital, while its disadvantage is...

  • Media scaremongering has less and less effect. BEDINGTON, ED // Meat Trades Journal;2/28/2014, p3 

    The author focuses on the association of meat to Alzehiemer's and other degenerative disease, or cancer.

  • Alzheimer's disease: What we know now. Sikanovski, Daniela // Nursing Homes: Long Term Care Management;Jun98, Vol. 47 Issue 6, p56 

    Presents information on Alzheimer's disease in the United States. Pathology; Diagnosis; Treatment; Patient care.

  • A-82 Dysfunction in Executive Functioning in an Elderly Population with Diabetes Mellitus. Consbruck, F; Vagt, D; Mazur, L; Page, C; Mulligan, K; Webbe, F // Archives of Clinical Neuropsychology;Sep2014, Vol. 29 Issue 6, p533 

    Objective: Previous research on the implications of diabetes and dementia has shown conflicting results. In this study we report the level of impairment in executive functioning in a group of elderly individuals with comorbid Alzheimer's disease (AD) and Diabetes Mellitus (DM) as compared to...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics